Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy

Brain and Development

Volumn 34, Issue 4, 2012, Pages 293-297

  Murakami, Terumi ^a,b   Ishigaki, Keiko ^a   Shirakawa, Seigo ^a   Ikenaka, Harumi ^a   Sakauchi, Masako ^a   Osawa, Makiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Saiseikai Kurihashi Hospital   (Japan)

Author keywords

FKTN; Fukuyama congenital muscular dystrophy; Herpangina; Rhabdomyolysis; Viral infection

Indexed keywords

CREATINE KINASE; FUKUTIN; METHYLPREDNISOLONE; MYOGLOBIN; PREDNISOLONE;

ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; COXSACKIE VIRUS; CREATINE KINASE BLOOD LEVEL; DISEASE EXACERBATION; DRUG WITHDRAWAL; ECHO VIRUS; ENTEROVIRUS; FEMALE; FEVER; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; GENE INSERTION; HERPANGINA; HUMAN; HYPERCAPNIA; MALE; MUSCLE INJURY; MUSCLE WEAKNESS; PARALYSIS; PHARYNGITIS; PRESCHOOL CHILD; PROTEIN URINE LEVEL; SUMMER; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MYOSITIS; SEVERITY OF ILLNESS INDEX; VIRUS DISEASES; WALKER-WARBURG SYNDROME;

EID: 84858295288     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.06.002     Document Type: Article

References (15)

1. Fukuyama Y., Osawa M., Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type - Clinical, genetic and pathological considerations. Brain Dev 1981, 3:1-29.
2. Kobayashi K., Nakahori Y., Miyake M., Matsumura K., Kondo-Iida E., Nomura Y., et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998, 394:388-392.
3. Toda T., Kobayashi K. Fukuyama-type congenital muscular dystrophy: the first human disease to be caused by an ancient retrotransposal integration. J Mol Med 1999, 77:816-823.
4. Takeda S., Kondo M., Sasaki J., Kurahashi H., Kano H., Arai K., et al. Fukutin is required for maintenance of muscle integrity, cortical histiogenesis and normal eye development. Hum Mol Genet 2003, 12:1449-1459.
5. Obata R., Yasumi Y., Suzuki A., Nakajima Y., Sato S. Rhabdomyolysis in association with Duchenne's muscular dystrophy. Can J Anaesth 1999, 46:564-566.
6. Figarella-Branger D., Baeta Machado A.M., Putzu G.A., Malzac P., Voelckel M.A., Pellissier J.F. Exertional rhabdomyolysis and exercise intolerance revealing dystrophinopathies. Acta Neuropathol 1997, 94:48-53.
7. Kato R., Kawamura J., Sugawara H., Niikawa N., Matsumoto N. A rapid diagnostic method for a retrotransposal insertional mutation into the FCMD gene in Japanese patients with Fukuyama congenital muscular dystrophy. Am J Med Genet A 2004, 127A:54-57.
8. Ikenaka H., Kawahara M., Yanagaki S., Sumida S., Hirasawa K., Shishikura K., et al. Transient exacerbation of muscle weakness induced by febrile illness in patients with congenital muscular dystrophy. J Tokyo Wom Med Univ 2000, 70:E40-E46.
9. Fodili F., van Bommel E.F. Severe rhabdomyolysis and acute renal failure following recent Coxsackie B virus infection. Neth J Med 2003, 61:177-179.
10. Textbook of pediatric infectious diseases 2004, Saunders, Philadelphia. 5th ed.
11. Godfrey C., Escolar D., Brockington M., Clement E.M., Mein R., Jimenez-Mallebrera C., et al. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Ann Neurol 2006, 60:603-610.
12. Murakami T., Hayashi Y.K., Noguchi S., Ogawa M., Nonaka I., Tanabe Y., et al. Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol 2006, 60:597-602.
13. Suzuki Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 2005, 28:399-408.
14. Manzur A.Y., Kuntzer T., Pike M., Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 2008, CD003725.
15. Kam J.C., Szefler S.J., Surs W., Sher E.R., Leung D.Y. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993, 151:3460-3466.